📊 Score Breakdown
Offering Ability
20
Cash Runway
65
Float Risk
40
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
30%
🔄 Reverse Split
40%
• 50-day avg $1.78 approaching $1 threshold
• 9 months cash with weak price
📉 Score Deterioration
25%
• Score increased 11 points recently (worsening)
💰 Capital Raise
15%
• Under 12 months cash (9mo)
💹 Market Data
Market Cap$19.48M
Shares Outstanding5.44M
FloatN/A
Cash$1.04M
Debt$207.1K
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 86.5% shares (2025Q4 vs prior)
1 institutional holders · 8.3K shares
#1
UBS Group AG
8.3K shares
📉 Short Interest
Short Interest2.5K
Days to Cover1.0
% of FloatN/A
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
No recent SEC insights
📰 Recent News
No recent news
🔬 More Research for ZGM
📊 ZGM FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 ZGM Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.